Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00181987 · ClinicalTrials.gov registry record · Phase 4
Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 29
- Enrollment target
NCT00181987: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT00181987 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00181987, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 29 participants
- Enrollment target
Study Summary
The objective of this study is to investigate the safety and effectiveness of Concerta in the treatment of children (ages 5 to 17 years old) and adults (ages 18 to 55 years old) with Bipolar I, Bipolar II and Bipolar Spectrum Disorder and comorbid ADHD over 8 weeks. This study seeks to study the short-term effectiveness of a long acting formulation of methylphenidate (Concerta) in the treatment of children and adults with bipolar disorder and comorbid ADHD adequately stabilized on an acceptable and stable regimen of anti-mania agents.
Interventions
- DRUG methylphenidate HCl (Concerta)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2002-08 |
| Est. Completion | 2005-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00181987
The ClinicalTrials.gov registry entry for NCT00181987 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which methylphenidate HCl (Concerta) is the first listed.
NCT00181987 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00181987 about?
NCT00181987 is a clinical study titled "Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder". The objective of this study is to investigate the safety and effectiveness of Concerta in the treatment of children (ages 5 to 17 years old) and adults (ages 18 to 55 years old) with Bipolar I, Bipolar II and Bipolar Spectrum Disorder and comorbid ADHD over 8 weeks. This study seeks to study the sho...
What is the current status of trial NCT00181987?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 29 participants. The study started on 2002-08. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00181987?
The interventions under investigation include: methylphenidate HCl (Concerta) (DRUG).
Who is sponsoring clinical trial NCT00181987?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.